Ki-67 Index and Somatostatin Receptor Expression as Prognostic Markers in Patients with Pancreatic Neuroendocrine Tumours: A Review. Annals of Gastroenterology and Digestive Disorders, [S. l.], v. 8, n. 1, p. 5–9, 2025. DOI: 10.5281/zenodo.22202865. Disponível em: https://somatopub.com/index.php/AGDD/article/view/302. Acesso em: 31 oct. 2026.